Morgan Stanley Downgrades Healthpeak Properties to Hold

Morgan Stanley lowered its rating on Healthpeak Properties to hold with a $22 price target.

Written by Trueearnings · Published Jun 14, 2026, 2:00 AM EDT · Updated Jun 14, 2026, 8:00 PM EDT

Key Points

On June 11, 2026, Morgan Stanley downgraded Healthpeak Properties, Inc. (NYSE:DOC) to a hold rating with a $22 price target.
Healthpeak Properties' stock is trading at $20.69, with a market cap of about $14.26 billion and a P/E ratio of 64.7.
Insider activity includes recent purchases and sales by executives, and analysts have mixed ratings with a consensus price target around $21.06.

On June 11, 2026, Morgan Stanley analyst Richard Hill downgraded Healthpeak Properties, Inc. (NYSE:DOC) to a hold rating, setting a price target of $22. This change comes as the stock trades around $20.69 on the New York Stock Exchange.

Other Institutional Activity in Healthpeak Properties

Several major funds have recently adjusted their holdings in Healthpeak Properties. BlackRock, Inc. trimmed its stake by 182,068 shares, leaving it with 73,360,519 shares valued at about $1.21 billion. Vanguard Portfolio Management LLC established a new position with 58,125,899 shares worth approximately $955 million. Meanwhile, State Street Corp reduced its holdings by 872,866 shares, now holding 48,500,600 shares valued at around $796.9 million. JPMorgan Chase & Co notably increased its position by 14,056,729 shares, bringing its total to 44,731,541 shares worth about $740.3 million.

Healthpeak Properties Stock Snapshot

Shares of Healthpeak Properties, Inc. (NYSE:DOC) are trading near $20.69. The company has a market cap of approximately $14.26 billion and a P/E ratio of 64.7. The stock's 52-week range is between $15.70 and $20.82, with a 50-day moving average of $18.27 and a 200-day moving average of $17.72. Healthpeak has a current ratio of 2.04 and a quick ratio of 1.41, with a debt-to-equity ratio of 118.24.

Recent Earnings

In its latest earnings report, Healthpeak Properties reported revenue of $2.87 billion, reflecting a growth rate of 7.1%. The company achieved a net margin of 7.73% and a return on equity of 2.8%. Earnings per share stood at $0.32. The next earnings release is scheduled for July 23, 2026.

Dividend

Healthpeak Properties offers an annual dividend rate of $1.22, yielding 5.9%. The company's dividend payout ratio is 381.26%.

Insider Buying and Selling at Healthpeak Properties, Inc.

Recent insider transactions at Healthpeak Properties include EVP and Treasurer Ankit Patadia buying 1,358 shares at $15.46 on May 29, 2026, and selling 94 shares at $19.15 on the same day. Chief Financial Officer Kelvin Moses also purchased 937 shares at $15.46. President and CEO Scott Brinker sold 114 shares at $19.15.

Analysts Set New Price Targets

On June 11, 2026, Morgan Stanley downgraded Healthpeak Properties to a hold rating with a $22 price target. Previously, on June 1, Wells Fargo maintained a hold rating with a $20 target. Scotiabank also maintained a hold rating on May 27 with a $21 target. The consensus among 18 analysts is a buy recommendation, with a mean price target of approximately $21.06.

About Healthpeak Properties, Inc.

Healthpeak Properties, Inc. is a real estate investment trust (REIT) specializing in healthcare properties across the United States. Headquartered in Denver, Colorado, the company focuses on owning and developing medical offices, labs, and senior living facilities. Led by CEO Scott M. Brinker, Healthpeak has a diverse portfolio of 703 properties, including outpatient medical buildings, lab spaces, and continuing care retirement communities.

Bottom Line

Morgan Stanley's recent downgrade of Healthpeak Properties to a hold rating with a $22 target reflects cautious sentiment. Investors will be watching upcoming earnings and insider activity for further insights. As always, remember that these analyst ratings are based on past data and may not reflect current conditions.